THC Therapeutics, Inc. Quarterly Liabilities and Equity in USD from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
THC Therapeutics, Inc. quarterly Liabilities and Equity history and growth rate from Q2 2011 to Q1 2024.
  • THC Therapeutics, Inc. Liabilities and Equity for the quarter ending April 30, 2024 was $11.8K, a 11.5% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $11.8K -$1.53K -11.5% Apr 30, 2024 10-Q 2024-11-13
Q4 2023 $14.8K -$8.21K -35.7% Jan 31, 2024 10-Q 2024-09-05
Q3 2023 $11.7K -$44.9K -79.4% Oct 31, 2023 10-Q 2024-08-09
Q2 2023 $13K -$194K -93.7% Jul 31, 2023 10-Q 2024-11-13
Q1 2023 $13.3K -$202K -93.8% Apr 30, 2023 10-Q 2024-01-09
Q4 2022 $23K -$188K -89.1% Jan 31, 2023 10-Q 2024-01-08
Q3 2022 $56.6K -$253K -81.7% Oct 31, 2022 10-Q 2022-12-22
Q2 2022 $207K -$273K -56.9% Jul 31, 2022 10-K 2024-02-26
Q1 2022 $215K -$26.6K -11% Apr 30, 2022 10-Q 2022-06-16
Q4 2021 $211K +$14K +7.08% Jan 31, 2022 10-Q 2022-05-16
Q3 2021 $309K +$270K +694% Oct 31, 2021 10-Q 2022-05-16
Q2 2021 $480K +$395K +462% Jul 31, 2021 10-K 2022-11-25
Q1 2021 $242K +$10.3K +4.43% Apr 30, 2021 10-Q 2021-06-22
Q4 2020 $197K -$52.4K -21% Jan 31, 2021 10-Q 2021-03-29
Q3 2020 $39K -$379K -90.7% Oct 31, 2020 10-Q 2020-12-17
Q2 2020 $85.3K -$435K -83.6% Jul 31, 2020 10-K 2022-03-31
Q1 2020 $232K +$131K +129% Apr 30, 2020 10-Q 2020-06-22
Q4 2019 $249K +$140K +129% Jan 31, 2020 10-Q 2020-03-23
Q3 2019 $418K -$2.09M -83.4% Oct 31, 2019 10-Q 2019-12-23
Q2 2019 $520K -$2M -79.4% Jul 31, 2019 10-K 2020-11-04
Q1 2019 $101K Apr 30, 2019 10-Q 2019-06-14
Q4 2018 $109K Jan 31, 2019 10-Q 2019-03-15
Q3 2018 $2.51M Oct 31, 2018 10-Q 2018-12-19
Q2 2018 $2.52M Jul 31, 2018 10-K/A 2019-11-18
Q1 2014 $178K -$376K -67.9% Apr 30, 2014 10-Q 2014-06-12
Q4 2013 $179K -$394K -68.7% Jan 31, 2014 10-Q 2014-06-12
Q3 2013 $184K -$389K -67.9% Oct 31, 2013 10-Q 2014-06-11
Q2 2013 $193K -$403K -67.6% Jul 31, 2013 10-Q 2014-06-12
Q1 2013 $554K +$361K +187% Apr 30, 2013 10-Q 2013-06-11
Q4 2012 $573K Jan 31, 2013 10-Q 2013-03-21
Q3 2012 $573K Oct 31, 2012 10-Q 2012-12-14
Q2 2012 $595K +$595K Jul 31, 2012 10-K 2014-06-09
Q1 2012 $193K Mar 14, 2012 10-Q 2014-06-11
Q2 2011 $0 Jul 31, 2011 10-K 2012-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.